These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19339236)

  • 1. Quality of ceftriaxone in Pakistan: reality and resonance.
    Obaid A
    Pak J Pharm Sci; 2009 Apr; 22(2):220-9. PubMed ID: 19339236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical quality of ceftriaxone generic drug products compared with Rocephin.
    Lambert PA; Conway BR
    J Chemother; 2003 Aug; 15(4):357-68. PubMed ID: 12962364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical quality of eight generics of ceftriaxone preparation for injection in Eastern Asia.
    Arnet I; Altermatt M; Roggo Y; Schnetzler G
    J Chemother; 2015; 27(6):337-42. PubMed ID: 25144924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substandard medicines in resource-poor settings: a problem that can no longer be ignored.
    Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J
    Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceuticals--strategic considerations in health reforms in Pakistan.
    Nishtar S
    J Pak Med Assoc; 2006 Dec; 56(12 Suppl 4):S100-11. PubMed ID: 17595837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counterfeit and substandard antimalarial drugs in Cambodia.
    Lon CT; Tsuyuoka R; Phanouvong S; Nivanna N; Socheat D; Sokhan C; Blum N; Christophel EM; Smine A
    Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1019-24. PubMed ID: 16765399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence.
    Kelesidis T; Kelesidis I; Rafailidis PI; Falagas ME
    J Antimicrob Chemother; 2007 Aug; 60(2):214-36. PubMed ID: 17550892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of phenobarbital solid-dosage forms in the urban community of Nouakchott (Mauritania).
    Laroche ML; Traore H; Merle L; Gaulier JM; Viana M; Preux PM
    Epilepsia; 2005 Aug; 46(8):1293-6. PubMed ID: 16060942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical quality by design: product and process development, understanding, and control.
    Yu LX
    Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brands or generics: the dilemma of pharmaceutical marketing in a developing country.
    Quraeshi ZA; Luqmani M; Malhotra N
    J Health Care Mark; 1983; 3(4):27-37. PubMed ID: 10264767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of counterfeit anthelminthic medicines: a cross-sectional survey in Cambodia.
    Khan MH; Okumura J; Sovannarith T; Nivanna N; Akazawa M; Kimura K
    Trop Med Int Health; 2010 May; 15(5):639-44. PubMed ID: 20214756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making medicines safe.
    Videau JY
    Bull World Health Organ; 2001; 79(2):87. PubMed ID: 11242826
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substandard and counterfeit medicines.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality of amoxicillin formulations in some Arab countries.
    Kyriacos S; Mroueh M; Chahine RP; Khouzam O
    J Clin Pharm Ther; 2008 Aug; 33(4):375-9. PubMed ID: 18613855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.
    Cohen JC; Mrazek M; Hawkins L
    Clin Pharmacol Ther; 2007 Mar; 81(3):445-9. PubMed ID: 17251983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Counterfeit medicines: a growing threat].
    Barbereau S
    Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.